Altimmune, Inc. (ALT) NASDAQ

3.61

-4.1(-53.18%)

Updated at June 26 04:00PM

Currency In USD

Valuation

Market Cap511.93M
Enterprise Value476.69M
P/E Ratio-3.02
PEG Ratio-0.51
Price/Sales Ratio14,639.81
Price/Book Ratio1.92
Enterprise/Revenue12,184.61
Enterprise/EBITDA-2.69

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterMarch 31, 2025

Profitability

Profit Margin-4,512
Operating Margin-4,909.65

Management Effectiveness

Return On Assets-0.57
Return On Equity-0.65

Income Statement

Revenue20,000
Revenue/Share0
Gross Profit20,000
EBITDA-94.81M
Net Income-95.06M
Diluted EPS-1.34

Balance Sheet

Total Cash149.83M
Total Cash/Share1.98
Total Debt0
Total Debt/Equity0
Current Ratio15.85
Book Value Per Share1.88

Price History

52-Week Change-42.33
52-Week High11.16
52-Week Low2.91
Moving Average 50 Days5.72
Moving Average 200 Days6.57

Statistics

Average Volume2.9M
Shares Outstanding81.11M
% Held by Institutions50.48

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:30
Last Split DateSeptember 14, 2018